US9891239 — Modulators of pharmacokinetic properties of therapeutics
Method of Use · Assigned to Gilead Sciences Inc · Expires 2029-09-03 · 3y remaining
What this patent protects
This patent protects a compound and its therapeutic methods, including administration with at least one additional therapeutic agent.
USPTO Abstract
The present application provides for a compound of Formula IV, or a pharmaceutically acceptable salt, solvate, and/or ester thereof, compositions containing such compounds, therapeutic methods that include the administration of such compounds, and therapeutic methods and include the administration of such compounds with at least one additional therapeutic agent.
Drugs covered by this patent
- Tybost (COBICISTAT) · Gilead Sciences
FDA Patent Use Codes
When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.
| Code | Description | Drug |
|---|---|---|
U-257 |
— | Tybost |
U-257 |
— | Tybost |
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.